TOLTILVI Trademark

Trademark Overview


On Monday, September 26, 2016, a trademark application was filed for TOLTILVI with the United States Patent and Trademark Office. The USPTO has given the TOLTILVI trademark a serial number of 87182954. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 14, 2018. This trademark is owned by Glaxo Group Limited. The TOLTILVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, rheumatoid arthritis, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines
toltilvi

General Information


Serial Number87182954
Word MarkTOLTILVI
Filing DateMonday, September 26, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 14, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, rheumatoid arthritis, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 29, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, May 14, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 14, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 20, 2018ASSIGNED TO EXAMINER
Tuesday, October 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 28, 2017LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, June 28, 2017ASSIGNED TO LIE
Monday, December 12, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 12, 2016LETTER OF SUSPENSION E-MAILED
Monday, December 12, 2016SUSPENSION LETTER WRITTEN
Monday, December 12, 2016ASSIGNED TO EXAMINER
Thursday, September 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 29, 2016NEW APPLICATION ENTERED IN TRAM